Data Bridge Market Research

Hernia Mesh Repair Devices Market Players Are Johnson & Johnson Services, Inc., Medtronic, B. Braun Melsungen: Hernia Mesh Like Inguinal, Incisional, Umbilical, Femoral, Hiatal, Parastomal, Others


Pune, India -- (SBWIRE) -- 06/18/2018 -- Segmentation: Global Hernia Mesh Repair Devices Market

Global Hernia Mesh Repair Devices Market By Product Type (Synthetic Mesh, Biologic Mesh), By Hernia Mesh (Inguinal Hernia, Incisional Hernia, Umbilical Hernia, Femoral Hernia, Hiatal Hernia, Parastomal Hernia, Others), By Geography (North America, Europe, APAC, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Get Free Sample Report @

Drivers: Global Hernia Mesh Repair Devices Market

Hernia happens when the intestine, organ or fatty tissue comes through a gap in the adjacent muscle or connective tissue. A hernia mostly occurs at the abdominal wall. Hernia mesh repair devices market is growing due to increasing hernia surgeries. Inguinal hernia repair surgery is the most common general surgical procedure in developed economies, with a frequency of approximately 200 operations per 100 000 persons every year. Using the mesh-based techniques, the surgical procedures are made easy and they can be either open or minimally invasive.

According to National Center for Biotechnology Information, out of 107,838 groin hernia repairs 103,710 operations were registered prospectively and from 104,911 inguinal hernia cases 5280 were taken into consideration on emergency basis, when compared with 1068 of 2927 femoral hernias. Femoral hernia operations comprised 1.1% of groin hernia operations on men and 22.4% of operations on women.


A hernia can be reduced if it occurs occasionally and can be strapped back into the intestinal cavity, and it can be complicated if it remains for long period outside the abdominal cavity.

According to National Center for Biotechnology Information, the prevalence of inguinal hernia in Ghana is 3.15%. Symptomatic hernia cases were 530,082. The annual incidence of symptomatic hernias is 210 per 100,000 populations. Ghana hernia repair rate was 30 out of 100,000; a backlog of 1 million hernias was in need of repair. The cost of repairing all symptomatic hernias in Ghana is estimated at USD 53 million, and USD 106 million would be required to eliminate hernias over a period of 10 years.


A mesh is an antiseptic knitted material developed for the implantation within the body. With the growing acceptance of tension-free hernia repair procedures, the demand for advanced and innovative meshes has also grown. The biologic meshes are used for the restoration of the natural connections of muscle and tissue in the abdomen. This diminishes the risk of contamination and lowers failure rates. These 3-D meshes can be easily applied, and it functions both as a plug and patch at the site of hernia.

Many major players have developed products to meet the rising demand of the advanced meshes. For example, the GORE DUALMESH PLUS Biomaterial provided by W. L. Gore & Associates Inc. is the initial two-surface hernia repair product which contains antimicrobial agents, which hinders the microbial growth.


Hernia is a common problem of the modern world with its incidence more in developing countries. A hernia can be abridged when it occurs and can be stopped back into the intestinal cavity, and it can be complicated if it remains for long period outside the abdominal cavity.

Below are some technologically advanced new products, launched by major players:

In June 2017, W. L. Gore & Associates, Inc. received a FDA approval of GORE SYNECOR product which is a biomaterial used in hernia repair surgeries.

In March 2016, W. L. Gore & Associates, Inc. launched GORE SYNECOR Biomaterial which can be used in hernia repair surgeries.

In 2014, Covidien launched Symbotex Composite Mesh that can be used in surgical laparoscopic and open ventral hernia repair.

In 2012, Covidien launched AccuMesh Positioning System to be used in laparoscopic ventral hernia repair.

For Any Query Speak to Expert @

Major Players: Global Hernia Mesh Repair Devices Market

De Puy Synthes (Johnson & Johnson Services, Inc.),
Medtronic, C. R. Bard, Inc.,
W. L. Gore & Associates Inc.,
Integra Life Sciences Corporation,
B. Braun Melsungen AG,
Atrium, Acelity (KCI Licensing),
Zimmer Biomet,
Baxter International Inc.
among others.


Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Johnson & Johnson Services, involved in multinational medical devices, pharmaceutical and consumer packaged goods manufacturing. The company operates through three business segments- Consumer, Pharmaceutical, and Medical Devices. The pharmaceutical segment offers a wide range of products for five major therapeutic applications—immunology, infectious diseases, neuroscience, oncology, and cardiovascular & metabolic diseases. The consumer segment of the company offers various products pertaining to baby care, oral care, skin care, women's health, and wound care. The medical devices segment of the company offers various devices to be used in therapeutic areas such as orthopedic, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care.

Johnson & Johnson has more than 265 operating companies across the United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. Ethicon US, LLC., subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products. Some of its subsidiaries include Janssen Pharmaceuticals (Belgium), Ethicon Inc. (U.S.), DePuy (U.S.), Neutrogena (U.S.), Synthes (Switzerland), Cordis Corporation (U.S.), LifeScan, Inc. (U.S.), Janssen-Cilag (U.S.), McNeil Consumer Healthcare (U.S.), Janssen Biotech, Inc. (U.S.), Ortho Clinical Diagnostics (U.S.), and Mentor Worldwide LLC (U.S.)..


Founded in 1949 and headquartered in Minneapolis, U.S.. Medtronic is the world's largest standalone medical technology development and a global healthcare solution company. The company operates in cardiac and vascular group (cardiac rhythm and heart failure, coronary and structural heart, aortic and peripheral vascular), minimally invasive therapies group (surgical solutions and patient monitoring & recovery), restorative therapies (spine, brain therapies, speciality therapies and pain therapies), and diabetes group (intensive insulin management, non- intensive diabetes therapies, Diabetes service and solutions).

The company operates in more than 155 countries worldwide with more than 260 locations in research and development, manufacturing and distribution, and education centers. The company's regional locations are Asia Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, North America, and Western Europe. Some of its subsidiaries include Medtronic Belgium S.A./N.V. (Belgium), Dantec Elettronica S.r.l. (Rome), Medtronic (Shanghai) Ltd. (China), Medtronic B.V. (Netherlands), Medtronic Xomed Limited (U.K) and many more.

Inquiry Before Buying @

Braun Melsungen AG:

Braun Melsungen AG was founded in 1839 and it is headquartered at Melsungen in Germany. It is one of the world's leading manufacturers and providers of healthcare solutions. The company operates through sixteen business segments- cardiac-thoracic surgery, diabetes care, infection prevention, laproscopic surgery, orthopaedic joint replacement, wound management, continence care and urology, extracorporeal blood treatment, infusion therapy, neuro surgery, pain therapy, degenerative spinal disorders, general open surgery, interventional vascular diagnostics and therapy, nutrition therapy, and ostomy care The general open surgery segment offers a wide range of products such as surgical instruments, wound closure staplers, seal and cut, ligature clips, electro surgery and power systems.

Braun product range comprises of 5000 different product out of which 95 percent are manufactured by the company. The company has offices and facilities in more than 50 countries. B. Braun and its subsidiaries currently employ more than 54000 people in more than 60 countries. Some of its subsidiaries are B. Braun Melsungen Inc. (U.S),B. Braun Medical Pvt. Ltd. (India),B. Braun Surgical GmbH (Germany), B. BraunAvitum AG (Colombia) among others. Together with its subsidiaries it manufactures, markets, and sells various healthcare products and services for intensive care units, anesthesia and emergency care, extracorporeal blood treatment, and surgical core procedures all over the world.

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818